nireEHU 
Subject
Genetic Engineering and Biotechnology
General details of the subject
- Mode
- Face-to-face degree course
- Language
- English
Teaching staff
| Name | Institution | Category | Doctor | Teaching profile | Area | |
|---|---|---|---|---|---|---|
| FULLAONDO ELORDUI-ZAPATERIECHE, ASIER | University of the Basque Country | Profesorado Agregado | Doctor | Bilingual | Genetics | asier.fullaondo@ehu.eus |
Competencies
| Name | Weight |
|---|---|
| Conocimiento actualizado de las áreas más activas de la Biología Molecular y la Biomedicina. | 16.0 % |
| Experiencia de trabajo en un laboratorio de investigación en el área. | 16.0 % |
| Capacidad para comenzar el trabajo experimental conducente al doctorado. | 16.0 % |
| Capacidad para comprender y, a nivel básico, evaluar críticamente un artículo de investigación en las áreas objeto del Máster. | 16.0 % |
| Capacidad para integrarse en una empresa biomédica biotecnológica como titulado superior. | 16.0 % |
| Capacidad para iniciar una tesis doctoral. | 16.0 % |
Study types
| Type | Face-to-face hours | Non face-to-face hours | Total hours |
|---|---|---|---|
| Lecture-based | 50 | 75 | 125 |
Training activities
| Name | Hours | Percentage of classroom teaching |
|---|---|---|
| Expositive classes | 56.0 | 32 % |
| Group discussion | 22.0 | 4 % |
| Text analysis | 47.0 | 4 % |
Assessment systems
| Name | Minimum weighting | Maximum weighting |
|---|---|---|
| Continuous evaluation | 0.0 % | 30.0 % |
| Multiple-choice examination | 0.0 % | 30.0 % |
| Practical tasks | 0.0 % | 40.0 % |
Learning outcomes of the subject
Updated knowledge about the main topics in Molecular Biology and Biomedicine.Ordinary call: orientations and renunciation
Attendance is compulsory, and attendance of 80% or more is required to pass the course. Attendance and participation, questions, discussion of articles, 60% of the evaluation Written work (The teacher will indicate the central points of each session, so that the students develop a short work (5-10 pages) of a subject of the program, at their choice) 40%.This method of assessment could be changed if the guidelines of the health authorities so provide. The appropriate modifications would be announced in due course, with the necessary strategies and tools to guarantee the right of the student to be evaluated with equity and fairness.
Extraordinary call: orientations and renunciation
Taking a written test of the entire syllabus.This method of assessment could be changed if the guidelines of the health authorities so provide. The appropriate modifications would be announced in due course, with the necessary strategies and tools to guarantee the right of the student to be evaluated with equity and fairness.
Temary
The course aims to give students an overview of the current issues in Medical Biotechnology, by highlighting those requiring genetic engineering to develop.SECTION I. THE BIOLOGY BEHIND THE TECHNOLOGY.
Introduction: an historical perspective. Fundamental technologies. Synthetic biology. The genetic basis of disease
SECTION II. PRODUCTION OF THERAPEUTIC AGENTS Modulation of gene expression. Protein therapeutics. Plant biotechnology: history, fundamentals and applications. Biotechnology for the production of omega-3 and other added value oils.
SECTION 3. DIAGNOSIS AND TREATMENT OF HUMAN DISEASE. Molecular diagnosis. Molecular diagnosis of cancer. Introduction to nanobiotechnology. Bioengineering, nanobiotechnology and nanomedicine. Advances in genetic edition techniques. Human gene therapy. Epigenetics. Stem cells and regenerative medicine. Forensic medicine.
SECTION 4. SOCIETAL ISSUES. Genetic and society.
PRACTICAL. Expression in Escherichia coli and purification of the Green Fluorescent Protein.
Bibliography
Compulsory materials
For each individual subject included in the program the student will be provided by the instructors with additional teaching aids (i.e Power Point presentations and other specialized references as reviews or research articles).Basic bibliography
Medical Biotechnology. Bernard R. Glick, Terry L. Delovitch, Cheryl L. Patten. First Edition (2014). ASM Press, Washington, USA.Molecular Biotechnology: Principles and Applications of Recombinant DNA. Fifth Edition (2017). Bernard R. Glick, Cheryl L. Patten. ASM Press, Washington, USA.